Trial Profile
A Phase II Study of SB-715992 (NSC-727990, IND-70273) in Advanced Renal Cell Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2013
Price :
$35
*
At a glance
- Drugs Ispinesib (Primary)
- Indications Renal cell carcinoma
- Focus Therapeutic Use
- 20 Jul 2012 Additional trial investigator identified as reported by ClinicalTrials.gov.
- 20 Jul 2012 Actual end date (1 May 2011) added as reported by ClinicalTrials.gov.
- 01 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.